Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma - ScienceDirect
Biomedicines | Free Full-Text | Temozolomide and Other Alkylating Agents in Glioblastoma Therapy | HTML
Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma | Cell Death & Disease
Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma - ScienceDirect
Frontiers | C8-Substituted Imidazotetrazine Analogs Overcome Temozolomide Resistance by Inducing DNA Adducts and DNA Damage | Oncology
Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival | BMC Neurology | Full Text
Transcriptional control of O6‐methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma - Happold - 2018 - Journal of Neurochemistry - Wiley Online Library
Voltammetric/UV–Vis study of temozolomide inclusion complexes with cyclodextrin derivatives - ScienceDirect
Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma
Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma | Cell Death & Disease
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial - The Lancet Oncology
Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma | Cell Death & Disease
Frontiers | Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment | Immunology
Cells | Free Full-Text | Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML
Biomedicines | Free Full-Text | Temozolomide and Other Alkylating Agents in Glioblastoma Therapy | HTML
Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome Temozolomide Resistance and Glioblastoma Regrowth | Molecular Cancer Therapeutics
Cells | Free Full-Text | Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML
Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression | Scientific Reports
Integrated genetic and metabolic landscapes predict vulnerabilities of temozolomide resistant glioblastoma cells | npj Systems Biology and Applications
Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience | Future Oncology
Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma | Oncogenesis
